Fractional shares
Get dividend payments
Odonate Therapeutics Inc (ODT) is a publicly traded healthcare business based in the US which employs around 150 staff. Odonate Therapeutics is listed on the NASDAQ and traded in US dollars.
To make comparing even easier we came up with the Finder Score. Costs, features, ease and range of investments across 30+ platforms are all weighted and scaled to produce a score out of 10. The higher the score the better the platform – simple.
Read the full methodologyAll investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Buying shares in just one company is generally considered a riskier bet than investing in a range of investments - AKA a "diversified portfolio". Experts generally recommend holding a mix of investments in specific assets and funds. Funds are ready-made portfolios of multiple companies' shares (potentially including Odonate Therapeutics), and the idea is that drops in the value of one constituent company's share price might be offset by rises in others.
Odonate Therapeutics is a major part of the NASDAQ, so it's included in many global funds and investment trusts, as well as tracker-style exchange traded funds (ETFs).
Review technicals and fundamentals to help you determine if now's a good time for you to invest.
View Odonate Therapeutics's price performance, share price volatility, historical data and technicals.
The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.
Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the Odonate Therapeutics P/E ratio, PEG ratio and EBITDA.
Odonate Therapeutics's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 0x. In other words, Odonate Therapeutics's shares trade at around 0x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the United States stock markets on average as of November 09, 2023 (20.44). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Odonate Therapeutics's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give None. Higher PEG ratios such as this can be interpreted as meaning the shares offer worse value given the current rate of growth.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Odonate Therapeutics's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Find out how to spot some of the best day trading stocks available in the UK and abroad, along with tips for managing your investment portfolio on a day-to-day basis.
We’ve tested, analysed and scored trading platforms to find the 10 best trading platforms in the UK, who they’re best for and the pros and cons.
Find out what Web3 is all about, including pros and cons of Web3 and how you can invest.
Some trading apps and platforms now offer competitive interest rates on uninvested cash.
We’ve tested, analysed and scored trading apps to find the 10 best trading apps in the UK, who they’re best for and the pros and cons.
We have listed the top forex trading platforms in the UK, who they’re best for and the pros and cons.
We’ve reviewed the best online trading platforms in the UK and explained why they’re best suited to beginners, with pros and cons.
A junior stocks and shares ISA account (JISA) is a tax-efficient way to save for your child’s future, here are the best options and how to compare.
We’ve reviewed the best stocks and shares ISA accounts in the UK, explaining who they might suit and what the benefits and drawbacks are.
Find out how to choose the best shares to buy now, see our list of the top 30 trending stocks today, and find out why they’re trending.